ANKZF1 inhibitors represent a class of chemical compounds that interact with and inhibit the activity of the ANKZF1 protein. The ANKZF1 protein, known for its ankyrin repeat and zinc finger domains, plays a role in various cellular processes, including DNA repair, protein degradation, and transcription regulation. Inhibitors of ANKZF1 often function by binding to its active sites, disrupting its interactions with other cellular components or directly interfering with its catalytic activity. This interference can influence downstream signaling pathways and affect cellular homeostasis, particularly in processes where ANKZF1 is heavily involved, such as cellular stress responses, genomic integrity maintenance, and proteasomal degradation pathways. Structurally, these inhibitors may possess moieties that enhance their affinity for ANKZF1's key binding sites, ensuring selectivity and potency in inhibiting the protein's function.
Chemically, ANKZF1 inhibitors are often composed of complex organic frameworks, including aromatic rings, heterocycles, and functional groups like amides, sulfonamides, or hydroxyl groups. These molecular features are critical for stabilizing interactions with the ANKZF1 protein, either through hydrophobic contacts, hydrogen bonding, or coordination with metal ions in the zinc finger domain. Understanding the structure-activity relationship (SAR) of these inhibitors is key to optimizing their inhibitory properties, as slight modifications in their structure can significantly affect their binding efficiency and overall activity. Advanced computational techniques, such as molecular docking and dynamics simulations, are often employed to model the interaction between ANKZF1 inhibitors and their target, providing insights into how different chemical groups contribute to their inhibitory behavior. Additionally, spectroscopic methods like NMR and X-ray crystallography are utilized to validate these interactions and elucidate the detailed molecular mechanisms underlying ANKZF1 inhibition.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, affecting downstream AKT signaling which can regulate transcription factors that control ANKZF1 expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, impacting stress response pathways that can alter ANKZF1 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, affecting AP-1 transcription factor activity, which can regulate ANKZF1 gene expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, affecting AKT signaling and potentially influencing pathways that regulate ANKZF1 stability. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, affecting cell growth pathways that can alter ANKZF1 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which can affect ERK pathway and transcriptional regulation mechanisms that can have an impact on ANKZF1 expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases, affecting phosphorylation states and signaling pathways that can modulate ANKZF1 activity. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
Inhibits Gs-alpha subunit of G-protein-coupled receptors, affecting cAMP pathways that can influence ANKZF1 expression. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Inhibits protein kinase C, which can affect downstream pathways that regulate ANKZF1 activity. | ||||||
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $68.00 $267.00 | 10 | |
Chelates calcium, disrupting intracellular calcium signaling that can affect pathways regulating ANKZF1 activity. | ||||||